Find uplifting stories about heroes, innovations, and solutions
16933 results for "vaccine research"
After 25 years at NBC News, Kristen Dahlgren left her dream job to solve a problem she discovered during her own breast cancer treatment: life-saving vaccine research wasn't reaching patients fast enough. Now she's partnering with one of America's top cancer research institutes to change that.
A Saskatchewan team has developed a groundbreaking vaccine that protects cattle from tuberculosis without interfering with disease testing. If approved, MSX-1 would be the world's first licensed bovine TB vaccine.
Researchers worldwide are developing vaccines that could protect against multiple flu strains for years, ending the need for annual shots. Around a dozen candidates are already in clinical trials.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
America's largest physicians group is partnering with university researchers to provide independent, evidence-based vaccine guidance for families and doctors. The move comes as families seek trusted, science-backed information about vaccine decisions.
Scientists achieved something that's never happened before: an HIV vaccine that starts working after just one dose. The breakthrough could transform how we fight a virus that's challenged researchers for decades.
A landmark study shows South Africa's free school vaccination program slashed HPV infections by 83%, proving the vaccine works even in regions with high HIV rates. For the first time, researchers confirmed that early vaccination protects girls living with HIV just as well as those without it.
Ethiopia's leading research institute just gained a powerful ally in the fight for better health across Africa. The World Health Organization is teaming up with the newly expanded Armauer Hansen Research Institute to develop vaccines, improve medicines, and strengthen health systems.
A rigorous study of 434 toddlers finds no connection between mRNA COVID vaccines during pregnancy and autism or developmental delays. The research offers strong reassurance for expectant mothers making vaccine decisions.
Scientists at La Jolla Institute and Scripps Research have created an HIV vaccine that triggered the strongest antibody response ever seen in primates. Human trials are now underway for a vaccine 14 years in the making.
Abu Dhabi's health authority is partnering with global pharmaceutical leader Sanofi to explore building a cutting-edge vaccine research center powered by AI and mRNA technology. The collaboration could accelerate how quickly new vaccines reach people who need them most.
%2Ffile%2Fattachments%2Forphans%2F2HIVVaccineResearch_437240.jpg)
When the US pulled funding for a groundbreaking HIV vaccine trial in Cape Town, South African scientists refused to quit. They found new backers and launched a scaled-down version that could reinvigorate global vaccine research.
African researchers are racing to develop the continent's first chikungunya vaccine designed specifically for children and local populations. Rwanda is leading a four-year, $17 million partnership across four African nations to test and eventually manufacture the life-saving vaccine.
A major new study of 434 children brings reassuring news for pregnant mothers: getting the COVID-19 mRNA vaccine during pregnancy shows no link to autism or developmental delays. The research tracked children up to 30 months old and found identical outcomes whether mothers received the vaccine or not.
Abu Dhabi is teaming up with global pharmaceutical company Sanofi to build a cutting-edge Vaccine Innovation Centre powered by artificial intelligence and mRNA technology. The facility will combine research, manufacturing, and pandemic preparedness under one roof to accelerate life-saving vaccine development.
After 14 years of research, San Diego scientists developed an HIV vaccine that successfully triggered virus-fighting antibodies in nearly half of the primates tested. The breakthrough could lead to the first effective HIV vaccine for humans within years.
A major Swedish study tracking nearly 60,000 women found no link between COVID-19 vaccination and reduced fertility, putting to rest persistent social media rumors. The research offers reassuring news for anyone who delayed vaccination due to pregnancy concerns.
University of Guelph researchers just cleared a major hurdle on a 20-year quest to create the world's first vaccine against campylobacter jejuni, the number one bacterial cause of severe diarrhea worldwide. The phase one human trial proved the vaccine is safe and effective at building immunity.
After a century with only one TB vaccine, three promising candidates are in final trials, led by South African researchers who could deliver a breakthrough by 2028. The new vaccines could prevent millions of deaths from a disease that still kills over 1.5 million people yearly.
A global research team discovered exactly why a tiny number of people developed blood clots after certain COVID-19 vaccines, and their breakthrough points the way to even safer vaccines. The answer lies in a single mutation that misdirects the immune system in extraordinarily rare cases.
Showing 20 of 16933